| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 04/16/1996 | US5508186 Has vp1 minor structural protein to vp2 major structural protein ratio higher than the ratio of naturally occurring full capsid |
| 04/11/1996 | WO1996010642A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | WO1996010641A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 04/11/1996 | WO1996010632A1 Recombinant negative strand rna virus expression systems and vaccines |
| 04/11/1996 | WO1996010580A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | DE4435907A1 Recombinant papilloma virus-like particles contg. L1 or L2 proteins |
| 04/11/1996 | CA2200629A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/10/1996 | EP0705344A1 Adenovirus vectors for gene therapy |
| 04/09/1996 | US5506271 Method of treating papilloma virus infection using hypericin |
| 04/09/1996 | US5506130 Contacting bottom of container surface with mixture of cells suspended in a media to permit desired cells bound to surface, separating unbound cells, removing bound cells, suspending in second media, repeating the above steps |
| 04/09/1996 | US5506129 Virus production |
| 04/09/1996 | US5506128 Recombinant infectious bovine rhinotracheitis virus |
| 04/09/1996 | US5505947 Attenuating mutations in Venezuelan Equine Encephalitis virus |
| 04/04/1996 | WO1996010088A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 04/04/1996 | WO1996010087A1 Method for treatment of cancers by regulating the activity of ras proteins |
| 04/04/1996 | WO1996010083A1 Novel pesticidal proteins and strains |
| 04/04/1996 | DE4441483C1 Use of bio-assimilated boron cpds. |
| 04/04/1996 | CA2197904A1 Deffective recombinant adenoviruses with inactivated iva2 gene |
| 04/03/1996 | EP0704533A1 An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus |
| 04/03/1996 | EP0703980A1 Intracellular binding proteins and use thereof |
| 04/02/1996 | US5503973 Method for inhibition of viral morphogenesis |
| 04/02/1996 | CA2107798C Method for testing blood units for viral contamination |
| 03/28/1996 | WO1996009408A1 Human galactokinase gene |
| 03/28/1996 | WO1996009374A1 Human galactokinase gene |
| 03/28/1996 | WO1996007749A3 Methods and compositions for inhibiting production of replication competent virus |
| 03/27/1996 | EP0703294A1 Marek's disease virus vaccine |
| 03/27/1996 | EP0702724A1 Mengovirus as a vector for expression of foreign polypeptides |
| 03/27/1996 | EP0702719A1 Process for the sterilization of biological compositions and the product produced thereby |
| 03/27/1996 | EP0702717A1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors |
| 03/27/1996 | CN1119459A Process for preparing cancer vaccines |
| 03/20/1996 | EP0702085A1 Recombinant infectious non-segmented negative strand RNA virus |
| 03/20/1996 | EP0702084A1 Recombinant retroviruses |
| 03/20/1996 | EP0701450A1 Recombinant viruses and their use in gene therapy |
| 03/20/1996 | EP0701401A1 Adenoviral vectors including dna encoding lung surfactant protein |
| 03/14/1996 | WO1996007749A2 Methods and compositions for inhibiting production of replication competent virus |
| 03/14/1996 | WO1996007748A1 Non self-inactivating, expression targeted retroviral vectors |
| 03/14/1996 | WO1996007734A2 Recombinant adenovirus comprising a chimeric penton base protein |
| 03/14/1996 | WO1996001615A3 Hepatitis a virus deletion mutants and vaccine formulations containing the same |
| 03/14/1996 | CA2199419A1 Methods and compositions for inhibiting production of replication competent virus |
| 03/14/1996 | CA2198861A1 Recombinant adenovirus comprising a chimeric penton base protein |
| 03/13/1996 | EP0701130A2 Device and process for cell capture and recovery |
| 03/12/1996 | US5498537 Serum-free, artificial capillary system cartridge |
| 03/12/1996 | US5498520 Method for testing blood units for viral contamination |
| 03/07/1996 | WO1996006941A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 03/07/1996 | WO1996006933A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 03/07/1996 | WO1996006619A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 03/07/1996 | WO1996003509A3 Insect viruses, sequences, insecticidal compositions and methods of use |
| 03/07/1996 | WO1995032291A3 Hepatitis g virus and molecular cloning thereof |
| 03/07/1996 | CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 03/07/1996 | CA2197427A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 03/06/1996 | EP0699758A1 Prototype felv isolates for use in disease models and vaccines |
| 03/06/1996 | EP0699240A1 Gibbon ape leukemia virus-based retroviral vectors |
| 03/06/1996 | EP0699076A1 Otitis media vaccine |
| 03/06/1996 | EP0315637B1 Polypeptides useful in diagnosis of mycoplasma infections in swine and recombinant-dna methods for manufacturing same |
| 02/29/1996 | WO1996006177A2 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 02/29/1996 | WO1996006164A1 Method for isolating mutant cells |
| 02/29/1996 | WO1996006159A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | WO1996005809A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 02/29/1996 | WO1996001324A3 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 02/29/1996 | CA2196892A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/28/1996 | EP0698108A1 Adenoviral vectors of animal origin and use thereof in gene therapy |
| 02/28/1996 | EP0698093A1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE |
| 02/28/1996 | EP0698091A1 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 02/28/1996 | EP0697893A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 02/28/1996 | CN1117742A Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
| 02/27/1996 | US5494807 NYVAC vaccinia virus recombinants comprising heterologous inserts |
| 02/25/1996 | CA2692337A1 Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions |
| 02/22/1996 | WO1996005321A1 Gene therapy for restenosis using an adenoviral vector |
| 02/22/1996 | WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 02/22/1996 | WO1996005294A1 Method for preparing an influenza virus, antigens obtained and applications thereof |
| 02/22/1996 | WO1996005293A1 Molecular presenting system |
| 02/22/1996 | WO1996005292A1 Antigenically-marked non-infectious retrovirus-like particles |
| 02/22/1996 | WO1996005291A1 Recombinant herpesvirus of turkeys and uses thereof |
| 02/22/1996 | WO1996004934A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/22/1996 | CA2197446A1 Antigenically-marked non-infectious retrovirus-like particles |
| 02/22/1996 | CA2196208A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/22/1996 | CA2174232A1 Gene therapy for restenosis using an adenoviral vector |
| 02/21/1996 | EP0697170A1 Coated pesticidal agents, processes for their preparation and compositions containing them |
| 02/21/1996 | CN1117081A Triple live vaccine and toxin vaccine for distemper, rabies and pavovirus and its preparing method |
| 02/20/1996 | US5492314 Preloaded digressive rate mount |
| 02/15/1996 | WO1996004395A1 Recombinant virus vectors |
| 02/15/1996 | WO1996004394A1 Hsv viral vector |
| 02/15/1996 | WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | WO1996004384A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004383A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004020A1 Infectious hiv-2 strains and non-human primates infected therewith |
| 02/15/1996 | WO1996003997A2 Treatment of cancer using hsv mutant |
| 02/15/1996 | CA2328638A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | CA2196168A1 Recombinant virus vectors |
| 02/15/1996 | CA2195965A1 Hsv viral vector |
| 02/15/1996 | CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/14/1996 | EP0696326A1 Methods of treating and detecting cancer using viruses |
| 02/14/1996 | EP0696206A1 Adenoviruses having modified fiber proteins |
| 02/14/1996 | EP0696204A1 Recombinant fowlpox viruses and uses thereof |
| 02/13/1996 | US5491076 Heterologous protein in plants |
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
| 02/08/1996 | WO1996003517A1 Process for preparing viruses and viral vectors |
| 02/08/1996 | WO1996003509A2 Insect viruses, sequences, insecticidal compositions and methods of use |
| 02/08/1996 | WO1996003508A1 Dna encoding ovine adenovirus (oav287) and its use as a viral vector |